Institutions / Seven Fleet Capital Management LP / Holdings
Back to Seven Fleet Capital Management LP

Seven Fleet Capital Management LP

All holdings · as of Dec 31, 2025

85 positions

CompanyClassValueShares% of portfolio
CG Oncology, Inc.—$62.91M1,515,15147.8%
SOLENO THERAPEUTICS, INC.—$6.02M130,0794.6%
Revolution Medicines, Inc.—$5.24M65,8004.0%
Liquidia CorpLQDACommon Stock$3.15M91,2672.4%
Compass Therapeutics, Inc.—$3.05M568,7472.3%
EXELIXIS, INC.—$3.01M68,5692.3%
Axsome Therapeutics, Inc.—$2.37M12,9551.8%
Tyra Biosciences, Inc.—$2.09M79,5601.6%
Cogent Biosciences, Inc.—$1.92M54,0251.5%
Tango Therapeutics, Inc.—$1.91M215,1721.4%
Xencor Inc—$1.68M109,5541.3%
Pharvaris N.V.—$1.54M55,3421.2%
Terns Pharmaceuticals, Inc.—$1.49M36,8941.1%
BELITE BIO, INCBLTEADR$1.47M9,1611.1%
Dyne Therapeutics, Inc.—$1.37M70,1801.0%
Nuvalent, Inc.—$1.27M12,6011.0%
ASCENDIS PHARMA A/S—$1.21M5,6700.9%
AMICUS THERAPEUTICS INC—$1.17M82,5000.9%
VAXCYTE, INC.—$1.17M25,3650.9%
Avalo Therapeutics, Inc.—$1.15M63,3430.9%
Inhibikase Therapeutics, Inc.—$1.09M533,6480.8%
MADRIGAL PHARMACEUTICALS, INC.—$1.08M1,8600.8%
GERON CORP—$1.03M777,8800.8%
Krystal Biotech, Inc.—$986.2K4,0000.8%
LeonaBio, Inc.LONACommon Stock$968.6K127,9510.7%
Taysha Gene Therapies, Inc.TSHACommon Stock$919.7K167,2230.7%
Silence Therapeutics plcSLNADR$897.4K147,6000.7%
Zura Bio Limited—$872.5K166,5000.7%
AGIOS PHARMACEUTICALS, INC.—$863.9K31,7380.7%
Praxis Precision Medicines, Inc.—$795.8K2,7000.6%
Celcuity Inc.CELCCommon Stock$782.9K7,8490.6%
KalVista Pharmaceuticals Inc—$781.9K48,4120.6%
PALISADE BIO, INC.—$769.6K327,5000.6%
Relmada Therapeutics, Inc.—$744.3K154,1090.6%
PROTAGONIST THERAPEUTICS INC—$698.7K8,0000.5%
CIDARA THERAPEUTICS INC—$668.4K3,0260.5%
Cytokinetics Inc—$656.7K10,3350.5%
NEKTAR THERAPEUTICS—$634.2K15,0000.5%
United Therapeutics Corp—$633.4K130,0000.5%
Relay Therapeutics, Inc.—$617.6K73,0000.5%
Dianthus Therapeutics, Inc.—$603.8K14,6510.5%
MBX Biosciences, Inc.MBXCommon Stock$574.0K18,2000.4%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$553.2K15,2430.4%
Evolus, Inc.—$545.3K82,0000.4%
ZYMEWORKS INC.—$542.4K20,6000.4%
Corbus Pharmaceuticals Holdings, Inc.CRBPCommon Stock$461.9K56,7500.4%
Viridian Therapeutics, Inc.—$456.0K14,6540.3%
PROTHENA CORP PUBLIC LTD CO—$413.5K43,3000.3%
Nurix Therapeutics, Inc.—$379.4K20,0000.3%
Savara IncSVRACommon Stock$378.5K62,7620.3%
← PrevPage 1 of 2Next →